Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026)
Aura Biosciences (AURA) reported Other Non Operating Income of $2000.0 for Q1 2026, up 108.33% on a YoY basis from $960.0 in Q1 2025, and down 99.89% quarter-over-quarter from $1.9 million in Q4 2025.
Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026) Analysis & Trends
Aura Biosciences has reported Other Non Operating Income for 6 years, with the latest figure at $2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 108.33% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 51.93% YoY), and the FY2025 full-year result was $1.8 million, up 50.84% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $2000.0, down from $1.9 million in the prior quarter.
- The five-year high for Other Non Operating Income was $1.9 million in Q4 2025, with the low at -$329000.0 in Q3 2022.
- Historically, Other Non Operating Income has averaged $169882.4 across 5 years, with a median of -$24000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 732.69% — and 2024, when it soared 4973.08%.
- Aura Biosciences' Other Non Operating Income stood at $310000.0 in 2022, then slumped by 108.39% to -$26000.0 in 2023, then soared by 4973.08% to $1.3 million in 2024, then surged by 46.65% to $1.9 million in 2025, then sank by 99.89% to $2000.0 in 2026.
- The last three Other Non Operating Income figures came in at $2000.0 (Q1 2026), $1.9 million (Q4 2025), and -$13000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -36,000.00 |
| Mar 31, 2025 | -24,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -32,000.00 |
| Mar 31, 2023 | -13,000.00 |
| Dec 31, 2022 | 310,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Mar 31, 2022 | -44,000.00 |
| Sep 30, 2021 | 52,000.00 |